David Enloe Jr Net Worth & Insider Trades

David Enloe Jr - Chief Executive Officer, Recro Pharma, Inc

As of March 17, 2022

What is David Enloe Jr's Net Worth?

The current estimated net worth of Recro Pharma, Inc's Chief Executive Officer, David Enloe Jr, is estimated to be about $1 . David Enloe Jr owns about 524,879 units of Recro Pharma, Inc common stock. In the last 2 years at Recro Pharma, Inc, David Enloe Jr has sold an estimated value of $0 worth.

What is David Enloe Jr's Past Insider Trading?

David Enloe Jr's largest purchase order was 1,725 units , worth over $2.9K on November 16, 2021. In total, David Enloe Jr has made about 7 transactions over 2 years of their time at Recro Pharma, Inc. David Enloe Jr usually trades in January and December, with the busiest year in 2022. The most recent transaction was a purchase order of 512 units , worth over $1K on March 17, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was David Enloe Jr's Salary in 2020?

As Chief Executive Officer of Recro Pharma, Inc, David Enloe Jr has a total base salary of $10,577 . David Enloe Jr received compensation valued at about $1,072,800 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of stock awards of $660,001 , option awards of $400,544 , other compensation of $1,678 .

Recro Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. David Enloe, Jr. 2020 $10,577 - $660,001 $400,544 - $1,678 $1,072,800
Ryan D. Lake 2020 $198,985 $48,000 $1,058,040 $744,327 $107,640 $24,673 $2,181,665
Ryan D. Lake 2019 $319,777 $69,440 $623,276 $334,200 $138,880 $44,038 $1,529,611
Gerri Henwood 2020 $308,654 $111,240 - - - $21,166 $441,060
Gerri Henwood 2019 $553,846 - $2,608,537 $1,062,199 $360,000 $38,402 $4,622,984
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm

What are Recro Pharma, Inc's Past Insider Trades?

Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer,  Geraldine Henwood, Director,  and Scp Vitalife Partners Ii Lp .

Recro Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1